ARCHIVES

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 4 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

Interview: Von Eschenbach Says His Goal Is to Speed Development of Interventions

March 29, 2002

ACS Says Its Goals, Patients’ Coalition, Similar, Supports Bill

March 15, 1996

NCI To Recompete NSABP in 1995, Chabner tells Senate

May 20, 1994

Race, Age Play Role In Delay Of Surgery For Breast Cancer

December 28, 2007

NCI Offers Chlorozotocin

November 18, 1977

In Brief: Three Centers Win Comprehensive Designation; Hiatt Named Deputy Director, NCI Cancer Control

October 31, 1997